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ABSTRACT 
Retroviral oacogenes are genetic elements, tbe expressioa of wbicb is 
responslble for tbe traasformed pbeaotype of cells. These genes are 
derived from normal ceUular DNA seqaeaces caUed ceUalar protooaco-
geaes, wbicb are present in aU bamaa ceUs aDd seem to bave potential 
traasfol'llliDgabillty in tumon of DODYinl ori(pD, siace it is possäble tbat 
tbey undeJ'IO structural alteratioas aad/or cbaages in tbeir expressloa. 
Humaa skia tumors were aaalyzed in tbis study witb respect to tbe 
expressioa of tbe c-Jte protooacop~ tbe ceUalar bomolope of tbe 
Rous sarc:oma rirus traDsfol'llliDg ~~ by measuriag tbe enzymatic 
activity of its gene prod~ tbe pp60'- klDase activity. TyrosiDe-spedfic 
ldaase acdvity was detected in aU skiD tumors tested. Tbe expressloa 
pattem of tbe c-1te gene product Ia the melaaomas tested was differential 
aad varyiJag ldaase Ievels in difl'erent metastases from tbe same patient 
were detected. Tbe elevation of kiDase acdvity as compared to normal 
skia I'UIIed from about 4- to 10-fold. 
INTRODUcnON 
The genomes of all vertebrates, including humans, contain a 
variety of sequences which are potentially oncogenic. Some of 
these highly conserved sequences are homologaus to the trans-
forming genes of certain RNA tumor viruses and were thus 
designated cellular protaoneogenes (1-5). To date, three differ-
ent mechanisms leading to the activation of cellular protaon-
eogenes have been discussed. 
1. Mutation, either spontaneaus or induced by chemical 
carcinogens or irradiation, Ieads to a structurally altered prod-
uct of a cellular protaoneogene that might provoke the changes 
underlying neoplastic transformation. This mechanism of acti-
vation has been demonstrated for the c-ras gene in several solid 
tumors and tumor-derived celllines {6-8). 
2. Chromosomal rearrangement Ieads to an enhanced 
expression of the protaoneogene in question {9). Several pro-
taoneogenes have been mapped recently to chromosome re-
gions, which are known to be preferential breakpoints involved 
with the cytogenetic &Iterations associated with some human 
and murine malignant diseases (for review see Ref. 1 0). Espe-
cially in human Burkitt's Iymphoma and murine plasmocytoma 
specific rearrangement of the c-myc gene was shown { 11, 12). 
3. Amplification of a protaoneogene Ieads to multiple copies 
of the gene being repeatedly arranged on the chromosomal 
DNA or extrachromosomally as double minutes. This mecha-
nism of protaoneogene activation also causes enhanced expres-
sion and has been observed with c-myc, L-myc, and N-myc (13-
15). 
The c-src gene, a protaoneogene studied intensively with 
respect to its normal function ( 16-19), has not thus far been 
definitively associated with the causation and/or progression of 
human neoplasms. However, some intriguing Observations have 
been made. The c-src genein humans is located, as shown by 
in situ hybridization, on chromosome 20 (20). This chromo-
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some is involved in several rearrangement processes associated 
with a variety of malignant blood diseases (21). Expression of 
c-src in such tumor cells was detected in a systematic study on 
leukemic children. In many patients hybridization of a src-
specific probe to mRNA from tumor cells was reported, al-
though in some samples the signal was only very weak (22). 
However, in the case of one T-cell acute lymphoblastic leuke-
mia, one chronic myeloblastic leukemia, an osteosarcoma, and 
a Wilm's tumor the amount of c-src-specific mRNA was ele-
vated 4-8-fold. In an acute myeloblastic leukemia the amount 
of c-src transcripts was enhanced as much as 8-16-fold. Similar 
studies have also revealed elevated Ievels of c-src mRNA in cells 
of acute lymphoblastic and acute myeloblastic leukemia patients 
as compared to normal cells (23) and in two patients with 
chronic myeloblastic leukemia (24). 
A 4-20-fold enhanced enzymatic activity of the c-src gene 
product, a tyrosine-specific kinase, was found in some human 
sarcomas and mammary carcinomas (25). 
In some human melanomas chromosome aberrations con-
ceming chromosome 20 have been observed (26). Because c-src 
possibly could be involved in these rearrangements, its role in 
the process of melanoma formation either causative or second-
ary during tumor progression and metastases appears reasona-
ble to investigate. The c-src gene product to be investigated 
might be changed qualitatively and/or quantitatively. There-
fore, studying c-src expression on the mRNA Ievel by Northem 
or dot blot analysis appears not to be sufficient, because quali-
tative changes leading to a more enzymatically active protein 
product or to a protein with altered substrate specificity would 
not be detectable. Thus, we decided to study c-src expression in 
human melanoma and other skin tumors by detennination of 
its tyrosine-specific kinase activity, which reflects the ultimate 
gene action of the protooncogene. In addition we investigated 
the efTect of the cytostatic drug DTIC3 on the phosphorylating 
activity of the c-src protein product, the pp60C~, in vitro. 
MATERIALSAND METHODS 
Antisera. TBR sera were prepared by simultaneaus injection of RSV 
Scbmidt-Ruppin D and RSV Prque C strains into newbom rabbits by 
a modification (27) of tbe procedure described by Brugge and Erikson 
(28). 
Tumor Material. A total of 12 skin metastases (in-transit or distant 
metastases of 8 patients (A-1) suffering from malignant melanomas (4 
superficial spreading melanomas, 2 acrolentiginous melanomas, and 2 
of nodular type) were investigated (Table 1). Patients A, D, E, and I 
were not subjected to cytostatic treatment during therapy prior to 
excision ofthe metastases. Patients 8, F, G, and H bearing melanomas 
located on tbe limbs and exbibiting in-transit metastases were subjected 
to a twice repeated extracorporeal cytostatic perfusion. Studies on 
kinase activity in metastases after cytostatic drug tberapy were per-
formed on skin metastases wbi<:h appeared on the treated limb only 
after tbe end of the therapy. The metastases were excised in local 
anesthesia and immediately frozen in liquid nitrogen or clirectly pre-
pared on ic:e for the immunoprecipitation experiments. 
J The abbreviations usecl are: DTIC, (3,3-dimethyl-1-triazcno)-imidazole-4-
c:arboxamide (dacarbazine); RSV, Rous san:oma virus; TBR serum, antisera &om 
RSV tumor-bearing rabbits; pp60, M. 60,000 phosphoprotein; Ap4A, diadeno-
sinetetraphosphate. 
235 
c-src EXPRESSION IN HUMAN SKJN TUMORS 
Table I Cluuacteriution ofthe tumon investigated 
Patients A 8 D E F G H 
Age 4S 72 36 72 70 69 60 62 
Sex M F M M M F F F 
Oassification of primary NM• SSM SSM SSM NM ALM SSM ALM 
tumor 
Level of invasion V w 111 IV V IV IV V 
Tumor thickness (mm) s.o 2.6 2.5 3.6 19.0 2.2 3.3 ND 
Location of primary mela- Rigbtchest Left calf Left thigb Epigastrium Rigbt hal- Nail of Left calf Left hallux 
noma Iux rigbt 
hallux 
Location of skin metastases Rigbt ehest Left thigb Temple Left ehest Rigbt calf Rigbt thigb Left thigh Leftcalf 
Grade of pigmentation Heavy Amela- Amel- Sligbt Amelanotic Amela- Amel- Amela-
notic anotic notic anotic notic 
• NM, nodular melanoma; SSM, superflcial spreading melanoma; ALM, acrolentiginous melanoma; ND, not done. 
CeU Unes. Cell lines used in this study were the established human 
melanoma celllines SK-MelS (29), RPMI 5966 (30), Colo 38 (31), 
S 1/2, three different subclones (F9, E 10, 8 12) of the primary melanoma 
cellline STR (established by K. H. Westphal), a human nevus cellline 
(established by K. Ax), and human foreskin fibroblasts. The ceU lines 
were grown in Dulbecco-Vogt-modified Eagle's minimum essential 
medium supplemented with 10% fetal calf serum. Chicken embryo cells 
were prepared from 11-day-old embryos (Lohmann-Tierzucht GmbH, 
Cuxhaven, Federal Republic of Germany) and were maintained in 
Dulbecco-Vogt-modified Eagle's minimumessential medium contain-
ing S% newbom calf serum. Secondary cells were infected with cloned 
virus of the Schmidt-Ruppin-A strain of Rous sarcoma virus. 
Preparatioas of Cell Extracts and lmmuaoprecipitation. Tissue sam-
ples were lysed and clarified as described previously (16). The immu-
noprecipitation was carried out in antibody excess. Soluble protein (0.2 
mg) was incubated with S ,.1 TBR serum for at least 60 min at 4•c and 
precipitated with the protein A-bearing StQJJhy/ococcus aureus Cowan 
strain I. The bacterial-bound immunocomplex was washed and the 
protein kinase assay was carried out by a modification ( 16) of the 
method of Collett and Erikson (32). After S min the reaction was 
stopped. Further incubation did not increase the phosphorylation de-
gree of the pp6()R immunocomplex. For the Ap4A and DTIC experi-
ments, various concentrations of Ap4A and DTIC were added to the 
prewashed immunoprecipitates S min before the kinase reaction was 
started by addition of h-32P)A TP. 
Protein DetenniDadon. Determination of protein concentration in 
the supematant of the clarified cell lysates was carried out on trichlo-
roacetic acid-precipitated aliquots according to the method of Lowry et 
al. (33). 
Pbosphoamino Acid Analysis. 32P-Iabeled lgG was cut out of the gel, 
eluted from the gel, and processed for phospboamino acid analysis as 
described previously (16), following the method by Hunterand Sefton 
(34). 
Isolation of DNA and Hybridlzadon. DNA from human melanoma, 
from nontumoraus tissue surrounding the tumor, and from peripheral 
blood lymphocytes of healthy persons was prepared according to tbe 
method of Blin and StafTord (35). Ten 1'1 of either DNA were digested 
to completion with restriction enzymes EcoRI or Hindlll, run on 0.8% 
agarose gels transferred to a hybridization membrane (Gene screen 
plus; NEN, Dreieich, Federal Republic of Germany) by the alkaline 
transfer procedure. The filters were hybridized to the nick-translated 
600-base pair src-specific Pstl fragment F of clone SRA-2, encompass-
ing the tyrosine kinase domain of the viral src gene (36). Hybridization 
was carried out at 43•c in a bufTer containing 43% formamide and Sx 
standard saline citrate in the presence of 6 x 1 0' cpm 32P-Iabeled probe 
(specific activity, 6 x lOS cpm/,.g DNA). Subsequent washings were 
performed in O.Sx standard saline citrate at 63·c. 
Hlstology. Part ofthe metastases were faxed in 4% formaldehyde and 
embedded in paraffin. Sections 8 ,.m thick were stained with hematox-
ylin-eosin. Photographs were taken on the Ortholux Orthoplan pho-
tomicroscope. Film material was llford PAN F. 
RESULTS 
macroscopic view and stained sections of two melanomas are 
shown in Fig. I. We determined the expression ofthe pp6~ 
kinase activity by means of the immunocomplex kinase reaction 
in the presence of excess antiserum. AU melanomas tested show 
a kinase activity which is reactive with pp60"" antibodies (Fig. 
2). In any case the activity was elevated as compared to normal 
skin (Fig. 3). Quantitative determination of the kinase activity 
revealed varying kinase Ievels in the melanoma extracts of 
different patients and in the different metastases from the same 
patient (Fig. 3). A total of three different TBR sera were used 
throughout the experiments, all with the same results, whereas 
immunoprecipitates using a preimmune rabbit serum did not 
display significant kinase activity. While the melanoma of 
patient E showed a low kinase activity (compared to normal 
skin), the melanoma of patient I displayed kinase which is S 
times as active as that of patient E. Thus far no correlation 
between the pp6()"'C kinase activity and the pathological type of 
the melanoma is evident. Comparing different metastases of 
the same patient, we detected varying Ievels (factor of 2-3) of 
kinase activities in patients D and F but comparable activity in 
two metastases from patient G. 
To investigate if Cytostatic treatment during therapy has any 
effect on the pp60C".- kinase we compared the activity in differ-
ent metastases from one patient before and after treatment. 
Thus far no difference in kinase activity with respect to cyto-
static treatmentwas found (data not shown). 
In addition to biopsy material we determined the kinase 
activity in several established melanoma cell lines (Table 2). 
These cell lines also showed varying kinase Ievels ranging from 
1800 cpm/mg protein in SK-MelS to 700 cpm/mg in 51/2 
cells. As a control a nevus cellline was investigated. The nevus 
cellular nevus is a benign tumor arising from a localized, benign 
neoplasm of cells derived from epidermal melanocytes (37). 
The nevus cells are located either as foci in direct contact with 
the epidermis (junction nevi) or exclusively in the outer corium 
(dermal nevi). Since nevus cellular nevi are considered to be 
benign tumors of pigment cells, they are of the same histoge-
netic origin as malignant melanomas and are therefore more 
suitable as control tissue than is normal skin, the latter being 
of very heterogeneaus composition. Unfortunately it was not 
possible to receive sufficient biopsy material from nevi. We 
therefore tested a nevus cell line for comparison, which inter-
estingly displayed only low kinase activity, similar to the Ievels 
found in human foreskin fibroblasts (Table 2). Three ditTerent 
subclones of one primary cell line of a human melanoma were 
also tested and each showed pp60C:~ kin• activity. The Ievel 
of kinase activity, however, was different in each of the sub-
clones. To confii'ID that it is indeed the heavy chain of the 
Different types of human melanomas were analyzed for the pp6()"'C antibody which is phosphorylated in the in vitro kinase 
presence and expression of c-src-related sequences (Table 1). A assays, aliquots of each sample were run under nonreducing 
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tumor A tumor I 
Fig. 1. Mac:roscopic: and mic:rosc:opic: appearanc:e of melanoma metastases. A-C, tumor A. A, multiple pigmented skia metastases of a nodular melanoma on the 
skin of the right ehest of a 4S-year-old male. B, C, histologic:al pic:ture of the metastases. Tumor c:ells in pseudoalveolar ammgement and multiple melanophqes. B, 
x 110; C, x 260. D-F, tumor I. D, multiple amelanotic: skin in-transit metastases of an ac:rolentiginous melanoma of the left hallux of a 62-year-old female. 
Rec:urrenc:es 2-fold extracorporeal perfusion therapy. E, F, histologic:al pic:ture of the metastases. Large epithelioid tumor c:ells with polymorphaus nuc:lei and many 
mitoses. E, X 110; F, X 260. 
A BDCO:QnE FF)GGIH I 
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Fig. 2. Demonstration of the pp60D- kinase Ktivity in extrac:ts of human 
melanomas. Equal amounts of protein were immunoprec:ipitated with a pp60D--
reac:tive TBR serum, the kinase assay was performed, and the proteins were 
separated on an II% polyac:rylamide gel. 5JK, heavy c:hain of the anti-pp60"'-
immunoc:omplex. DII and Dillare different metastases of patient D, FII tbat of 
patient F, and GII that of patient G. 
conditions and the radioactivity was then detected in the Mr 
150,000 IgG band (data not shown). In order to establish that 
the IgG heavy chain phosphorylation was due to a tyrosine-
specific kinase activity, we perfonned two-dimensional phos-
phoamino acid analyses; one example is shown in Fig. 4. The 
data indicated that there was only tyrosine phosphorylation. 
For further characterization we tested the kinase activity in the 
presence of Ap4A, a compound which exhibits an inhibitory 
effect on the viral pp6()- kinase activity but does not seem to 
affect the cellulai' enzyme in concentrations up to 100 ~o&M (38). 
In all cases tested, tbe kinase activity was insensitive towards 
inhibition by Ap4A in concentrations ranging from 1-100 ~o&M 
(data not shown). Thus far wehavenot detected any differences 
in the biochemical P,roperties of tbe immunoprecipitated kinase 
activity from human melanoma compared to pp60C..pc kinase 
activity from normal tissues from different species (16, 18). 
Because the antitumor agent DTIC is widely used in mela-
noma therapy, we investigated whether this drug has any efTect 
on tbe activity of the protaoneogene product pp6()C-"'". Addition 
of DTIC to the immunoprecipitates before starting the in vitro 
kinase assay led to a concentration-dependent inhibition of the 
tyrosine-specific kinase activity from human melanomas as weil 
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Fig. 3. Quantitative analysis of p~ kinase activity in extracts of human 
melanoma. Experimental details as desc:ribecl in Fig. 2. After the gel was stained, 
the heavy chain lgG band was cut out of the gel, and the counts were eluted and 
counted in a liquid scintillation counter. A-1, melanomas from different patients. 
Dll, Dill, different metastases from patient 0, Fll that from patient F, and GI/ 
that from patient G (•). As a control p~ kinase activity was determined in 
extracts of normal human skin. Each sample was assayed 6 times. SO ±S%. 
Table 2 QIIIUititlllive ütermillllJion of ppMY- Jci~U~Se lldivity in l11mum 
tMIIUIDmll celllines 
Experimentaldetailsare as described in Figs. 2 and 3. SO ±5%. 
Cellline 
SK-Me 15 
RPMI 5966 
Colo 38 
51/2 
STR-F9 
STR-E10 
STR-812 
Nevus cellline 
Human foreskin fibroblasts 
cpm/mg protein 
1800 
1300 
1200 
700 
6000 
4000 
2000 
300 
300 
as the pp60'"' k.inase activity from RSV -transformed cells (Fig. 
5). The concentrations of DTIC which led to a 50% inhibition 
of the kinase activity were 3.6 mg/ml for ·the viral kinase, 3.3 
mg/ml for the cellular kinase from chick embryo cells, 1.6 mg/ 
ml for the kinase from melanoma A, 2.8 mg/ml for the kinase 
from melanoma D, and 2.4 mg/ml for the kinase from mela-
noma I. 
Todetermine whether the elevated kinase activity is a specific 
characteristic of melanoma or more characteristic of integu-
mental cancers in general, we investigated a human skin tumor 
of a histogenesis different from that of melanoma. This tumor 
was excised from the right scapula of a 62-year-old patient 
(female) and was diagnosed as liposarcoma. After immunopre-
cipitation with TBR serum and subsequent performance of the 
kinase assay, we could show that the tumor cells display an 
increased kinase activity compared to the surrounding nontu-
moraus adipose tissue of the same patient and to adipose tissue 
of a healthy person (Fig. 6). Elevation in the tumor was deter-
mined to be 8-1 0-fold. 
To investigate whether the expression of c-src in human 
Fig. 4. Two-dimensional thin layer electrophoresis of »P-labeled beavy cbain 
of TBR-IgG after precipitation of melanoma I extract. Tbe l2p-labeled beavy 
chain was eluted from the gel and hydrolyzed. and the phosphoamino acids were 
separated by electrophoresis at pH 1.9 in the rust dimension and pH 3.9 in the 
second dimension. P-$ER, pbosphoserine; P-THR, pbosphotbreonine; P-TYR, 
phospbotyrosine. 
2 I. 6 8 10 
OTI C [mg/ml] 
Fig. S. Effect of OTIC on p~ kinase activity immunoprecipitatecl from 
melanoma I extracts (x) aad from pp60..._ ldnase ac:tivity immunoprecipitated 
from Scbmidt-Ruppin strain A RSV-transformed cllick embryo cells (e). Exper-
imental details are as described in Fig. 2 and "Materials and Methods." 
1 2 3 
53 K 
Fig. 6. Demonstration of the pp60"- kinase ac:tivity in extnds of a human 
liposan:oma (IAne 1), nontumoraus adipose tissue of the same patient (IAne 2), 
and adipose tissue of a healthy person (IAne 3). Experimentaldetails as describecl 
in Fig. 2. 
melanoma might be accompanied by gross structural changes 
in the c-src gene, we performed a Southem blot analysis of 
DNA isolated from human melanoma I which showed the 
highest Ievels ofkinase activity. Hybridization to a v-src-specific 
probe revealed 19-kilobase restriction fragments in EcoRI di-
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19kb-
-14kb 
a b cd 
Fis- 7. c-m: sequenc:es in DNA isolated from melanoma I (Liutn a and c) and 
from peripheral blood lymphocytes (LAita b and d). L4lta a and b, &oRI-
digested DNA; Ltuw c and d, Hilldlll-di&ested DNA. For further details see 
.. Materials and Metbods. • kb, kilobase. 
gests and 14-kilobase fragments in Hindill digests (Fig. 7). 
DNA from peripheral blood lympbocytes of nontumoraus per-
sons showed the same intensity of bands and. fragment sizes as 
the melanoma DNA (Fig. 7). The same applies for DNA from 
the nontumoraus tissue surrounding the melanoma (data not 
shown). 
DISCUSSION 
pp60C"-" tyrosine-specific kinase activity was detected in all 
melanomas examined, independent of their histological struc-
ture. The expression pattem of kinase activity in the melanomas 
tested is differential, and a high or low Ievel of kinase activity 
seems more likely to be an individual feature of the single tumor 
case and not of a melanoma type in general. The finding that 
different metastases from the same patient show different Ievels 
of kinase activity tempted us to assume that c-src might be 
more involved in secondary changes during tumor progression 
than in the primary event of neoplastic transformation. This is 
also supported by the data on pp60C"-" kinase activities in cell 
lines. Different .lines are recognized by their individual kinase 
Ievel. The differences found in three subclones of one primary 
melanoma cell line point to the interpretation that elevated 
kinase activity as observed in subclone F9 is acquired during 
the processes of tumor progression in some of the transformed 
cells and is not related to the event of neoplastic transformation 
in the cells giving rise to the primary melanoma. If the latter 
would be the case, all subclones should have similar Ievels of 
kinase activity. 
The metastases from both the nodular melanomas showed a 
somewhat lower kinase activity than did the metastases from 
SSMandALM. 
were subjected to cytostatic drug therapy other than DTIC a 
cytostatic effect on kinase activity in metastases excised 1-2 
days following treatment. 
We h8ve shown that kinase activity is elevated considerably 
in some of the tumors and celllines investigated. To evaluate 
the biological and p8thological significance ofthat observation, 
several items must be taken into consideration. 
I. Although it was clearly shown in some in vitro systems 
th8t elevated pp6oc-- kinase activity alone is not sufficient to 
neoplastically transform cells (39, 40), a function during the 
process of tumor progression remains still possible. In that case 
a cooperation of c-src with one or more other activated pro-
taoneogenes in generating the neoplastic phenotype of the 
melanoma would be suggestive. For the human c-ras oncogene, 
it has been shown in several melanom8 celllines that this gene 
is 8ctiv8ted through either point mutation or amplification (41, 
42) and that the mutant c-ras is capable of neoplastic transfor-
mation of NIH3T3 cells. 
2. The activation of c-src leading to increased kinase activity, 
which is observed in our tumor samples, does not seem to be 
melanoma specific, because in 8 skin tumor of different histo-
genesisalso high Ievels of p~ kinase activity were observed. 
This is in agreement with our earlier findings in the experimen-
tal animal system of Xiphophonu, where we detected elevated 
kinase activity in 8 variety of tumors of neuroectodermal and 
mesenchymal origin (43, 44) and with the data on enhanced c-
src expression in some human blood cancers (23) and in some 
human sarcomas and mammary carcinomas (25). 
3. At present we cannot decide whether the elevation of 
pp6~ tyrosine kinase activity is due to enhanced c-src expres-
sion on the mRNA or protein Ievel or to a structurally altered 
pp60C"src that displays higher Ievels of activity. Interestingly 
Bolen et al. (45) recently described in a human neuroblastoma 
cell line an increased pp6Cr" tyrosine kinase activity which is 
associated with 8 unique amino-terminal tyrosine phosphoryl-
ation of the p~ itself and which is not associated with high 
Ievels of c-src transcripts or pp6(Y-src protein. Whether this 
structurally altered pp60W"' would recognize cellular substrates 
other than those recognized by the pp60C"-" from nontumoraus 
ceUs is still unclear. In addition increasing pp6~ kinase 
activity without an increase in the amount of c-src specific 
mRNA has been described recently during difTerentiation of 
HL-60 cells, a human leukemia cell line (46). In our flr5t 
attempt to investigate the nature of the elev8ted kinase activity 
in human melanoma, we could not detect any gross structural 
changes in the c-src gene of the tumor showing the highest 
Ievels of kinase activity. Obviously, rearrangement and/or am-
plification of the c-src gene may not be responsible in general 
for the elevated kinase activity in human tumors. 
The question if increased pp6oc--- kinase activity in tumors 
is a cause or consequence of neoplastic transfonn8tion remains 
to be answered. A detailed study on c-src expression on the 
mRNA Ievel including in situ hybridization, DNA transfection 
studies, and an extended biochemical analysis of p~ from 
human melanomas should help to contribute to an understand-
ing of the functional rate of pp60C.._ in tumors. 
The low kinase activity in patient E is probably due to the 
fact that in this case the tlimor did not form a compact mass. 
Instead, diffuse nests of small nodules were found throughout 
cutaneous and s.c. tissues, so that the test material may have 
contained connective tissue in addition to tumor tissue. 
The concentration-dependent inhibition of the pp60C"-" and ACKNOWLEDGMENfS 
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